Patents by Inventor Yannan Zhao

Yannan Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220331496
    Abstract: A tissue engineering material for nerve injury repair, a preparation method therefor and an application thereof. The tissue engineering material for nerve injury repair is an N-cadherin crosslinked linear ordered collagen scaffold. By crosslinking N-cadherin with a linear ordered collagen scaffold, the prepared tissue engineering material can efficiently induce migration of neural stem cells towards an injury region so that the neural stem cells are enriched in the injury region, and can effectively inhibit deposition of inhibitory factors such as chondroitin sulfate proteoglycan, promote differentiation of the neural stem cells into neurons, and then promote recovery of electrophysiological and motion functions. The N-cadherin crosslinked linear ordered collagen scaffold also has a stable ordered topological structure and excellent mechanical properties, and can be used to repair nerve injuries such as spinal cord injury.
    Type: Application
    Filed: April 21, 2020
    Publication date: October 20, 2022
    Inventors: Jianwu DAI, Weiyuan LIU, Yannan ZHAO, Bing CHEN, ZHIFENG XIAO
  • Publication number: 20220090193
    Abstract: Provided is a method including hybridizing a polynucleotide to a template, contacting a first template nucleotide 5-prime adjacent to a 5-prime-most nucleotide of the plurality of nucleotides that are complementary to the polynucleotide with a polymerase and a charge-tagged nucleotide, wherein the charge-tagged nucleotide is complementary to the first template nucleotide and includes a charge tag attached to a 5-prime polyphosphate of the charge-tagged nucleotide.
    Type: Application
    Filed: August 18, 2020
    Publication date: March 24, 2022
    Applicants: ILLUMINA, INC., ILLUMINA SINGAPORE PTE. LTD.
    Inventors: Yannan ZHAO, Kaitlin PUGLIESE, Erin GARCIA, Ludovic VINCENT, Anmiv PRABHU, Silvia GRAVINA, Sergio PEISAJOVICH, Yin Nah TEO, Xiangyuan YANG, Jeffrey MANDELL, Jonathon STUTCHMAN
  • Publication number: 20220040255
    Abstract: The present invention provides methods for remodeling gut microbiome to a desired state. The invention also provides in vitro screening platform for identifying novel agents that can remodel dysfunctional gut microbiome.
    Type: Application
    Filed: September 26, 2019
    Publication date: February 10, 2022
    Inventors: Reza M. Ghadiri, Luke J. Leman, Poshen B. Chen, Yannan Zhao, Ali Torkamani, Audrey Black
  • Publication number: 20210318265
    Abstract: Provided is a device, including a conductive channel and a number of polymerase molecules bound thereto, wherein the number is between one and five and the conductive channel is to detect incorporation of a nucleotide comprising a charge tag into a nascent polynucleotide by the polymerase, and each of the one or more polymerase molecules includes a hexahistidine tag, the conductive channel includes a multivalent nickel-nitrolotriacetic acid complex, and the hexahistidine tag is bound to the multivalent nickel-nitrolotriacetic acid complex. Also provided are a method of attaching a polymerase to a conductive channel of a device and a method of using the device.
    Type: Application
    Filed: June 12, 2020
    Publication date: October 14, 2021
    Applicant: ILLUMINA, INC.
    Inventors: Yannan ZHAO, Emily WELCH
  • Patent number: 10092620
    Abstract: The present invention provides cyclic compounds that are useful in preventing or treating atherosclerosis or related disorders. The invention also provides therapeutic methods for treating or preventing various diseases or disorders associated with or mediated by atherosclerosis. Further provided in the invention are methods of screening for anti-atherosclerotic cyclic peptides with improved properties.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: October 9, 2018
    Assignee: The Scripps Research Institute
    Inventors: M. Reza Ghadiri, Luke J. Leman, Yannan Zhao, Bruce E. Maryanoff
  • Patent number: 9650602
    Abstract: Methods for reprogramming cells by culturing the cells under a condition that allows formation of a three-dimensional cell aggregate are provided. The cells and cell aggregates obtained using the methods are also provided.
    Type: Grant
    Filed: March 13, 2012
    Date of Patent: May 16, 2017
    Assignee: INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY, CHINESE ACADEMY OF SCIENCES
    Inventors: Guannan Su, Yannan Zhao, Jianshu Wei, Bing Chen, Zhifeng Xiao, Jianwu Dai
  • Publication number: 20160250280
    Abstract: The present invention provides cyclic compounds that are useful in preventing or treating atherosclerosis or related disorders. The invention also provides therapeutic methods for treating or preventing various diseases or disorders associated with or mediated by atherosclerosis. Further provided in the invention are methods of screening for anti-atherosclerotic cyclic peptides with improved properties.
    Type: Application
    Filed: April 2, 2014
    Publication date: September 1, 2016
    Inventors: M. Reza GHADIRI, Luke J. LEMAN, Yannan ZHAO, Bruce E. MARYANOFF
  • Publication number: 20150050733
    Abstract: Methods for reprogramming cells by culturing the cells under a condition that allows formation of a three-dimensional cell aggregate are provided. The cells and cell aggregates obtained using the methods are also provided.
    Type: Application
    Filed: March 13, 2012
    Publication date: February 19, 2015
    Applicant: INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY, CHINESE ACADEMY OF SCIENCES
    Inventors: Guannan Su, Yannan Zhao, Jianshu Wei, Bing Chen, Zhifeng Xiao, Jianwu Dai